Table 4.
BPV indices | OR* | 95% CI | p Value | BPV indices | OR* | 95% CI | p Value |
---|---|---|---|---|---|---|---|
Target Mismatch (n=57) | No Target Mismatch (n=53) | ||||||
SBP SD | 1.94 | 0.63 to 6.02 | 0.250 | SBP SD | 6.61 | 1.40 to 31.1 | 0.017 |
SBP CV | 2.39 | 0.45 to 12.7 | 0.305 | SBP CV | 5.32 | 0.70 to 40.1 | 0.105 |
SBP SV | 2.56 | 0.81 to 8.09 | 0.109 | SBP SV | 5.96 | 1.20 to 29.6 | 0.029 |
Proximal vessel occlusion (n=58) | No proximal occlusion (n=52) | ||||||
SBP SD | 5.38 | 1.44 to 20.2 | 0.013 | SBP SD | 1.63 | 0.53 to 5.03 | 0.398 |
SBP CV | 8.14 | 1.19 to 55.5 | 0.032 | SBP CV | 1.49 | 0.35 to 6.25 | 0.588 |
SBP SV | 3.47 | 1.05 to 11.4 | 0.041 | SBP SV | 3.55 | 0.91 to 13.8 | 0.068 |
Good collaterals (n=60) | Bad collaterals (n=50) | ||||||
SBP SD | 5.78 | 1.23 to 27.2 | 0.027 | SBP SD | 1.85 | 0.60 to 5.74 | 0.289 |
SBP CV | 8.60 | 1.02 to 72.5 | 0.048 | SBP CV | 1.51 | 0.26 to 8.83 | 0.650 |
SBP SV | 3.82 | 1.15 to 12.7 | 0.029 | SBP SV | 2.09 | 0.58 to 7.47 | 0.258 |
*Adjusted for admission NIHSS, patient sex, tPA administration, symptomatic intracranial haemorrhage and admission glucose value.
BPV, blood pressure variability; CV, coefficient of variation; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; SV, successive variation; tPA, tissue plasminogen activator.